Regenica Biosciences, Inc. — Form D

Regenica Biosciences, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-31. The offering totals $20K, of which $20K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2019-01-31
• Form: D
• Accession: 0001382963-19-000006
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $20K
• Amount sold: $20K
• Investors: 2
• Date of first sale: 2019-01-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-331864

Issuer

• Name: Regenica Biosciences, Inc.
• CIK: 0001766279
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 8815 W. 3RD ST., LOS ANGELES, CA, 90048
• Phone: (619) 933-1328

Officers, directors & promoters (3)

More

• CIK 1766279 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search